Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Cover Story

Cover Story
Viewpoints on Integrative Dermatology, Part 1
05/08/2023
Peter Lio, MD, FAAD
Do you have patients asking about alternative treatment options? In this first installment of a series exploring integrative approaches in dermatology, Dr Peter Lio answers key questions to help you navigate the journey.
Do you have patients asking about alternative treatment options? In this first installment of a series exploring integrative approaches in dermatology, Dr Peter Lio answers key questions to help you navigate the journey.
Do you have patients asking...
05/08/2023
The Dermatologist
Cover Story
JAK Inhibitor Safety: What Did ORAL Surveillance Really Teach Us?
03/07/2023
Michael Cameron, MD, FAAD
The goal of this article is not to minimize safety concerns, but rather to promote a more nuanced and contextualized conversation on the appropriate use of Janus kinase inhibitors in dermatology.
The goal of this article is not to minimize safety concerns, but rather to promote a more nuanced and contextualized conversation on the appropriate use of Janus kinase inhibitors in dermatology.
The goal of this article is not...
03/07/2023
The Dermatologist
Cover Story
Establishing a Clinical Trials Practice
02/07/2023
Lawrence J. Green, MD, FAAD
Have you found yourself thinking, “I am interested in running a clinical trial, now what?” Dr Lawrence J. Green answers key questions to get you started on the road to conducting clinical trials in the office.
Have you found yourself thinking, “I am interested in running a clinical trial, now what?” Dr Lawrence J. Green answers key questions to get you started on the road to conducting clinical trials in the office.
Have you found yourself...
02/07/2023
The Dermatologist
Cover Story
Writing for Peer-Reviewed Dermatology Journals: 10 Essential Tips for First-Time Authors
12/08/2022
Peter A. Young, MPAS, PA-C; Melissa C. Leeolou, BS; Douglas DiRuggiero, DMSc, MHS, PA-C; Pallavi Basu, MD, MPH; Gordon H. Bae, MD; and Paradi Mirmirani, MD
Despite the recognized benefits, medical writing can intimidate many bright clinicians new to the iterative process.
Despite the recognized benefits, medical writing can intimidate many bright clinicians new to the iterative process.
Despite the recognized benefits,...
12/08/2022
The Dermatologist
Cover Story
Pediatric Teledermatology
10/19/2022
Marla Jahnke, MD, and Sandra Oska, MD
Telemedicine has radically changed the way physicians currently deliver care.
Telemedicine has radically changed the way physicians currently deliver care.
Telemedicine has radically...
10/19/2022
The Dermatologist
Cover Story
Diagnostic Challenges in Patients With Skin of Color
09/12/2022
Seemal R. Desai, MD
A growing awareness of how skin diseases present in patients with darker skin types is helping drive dermatologic practice forward.
A growing awareness of how skin diseases present in patients with darker skin types is helping drive dermatologic practice forward.
A growing awareness of how skin...
09/12/2022
The Dermatologist
Cover Story
The Pathophysiology of Itch and Upcoming Therapeutics
08/16/2022
Shawn Kwatra, MD
With new study results being announced at a dizzying pace, it is time for a reset of the itch landscape.
With new study results being announced at a dizzying pace, it is time for a reset of the itch landscape.
With new study results being...
08/16/2022
The Dermatologist
Cover Story
Food Allergies in Pediatric Atopic Dermatitis
06/10/2022
Lacey Kruse, MD, and Ashley Torkan Zilberstein, MD
Up to 40% of children with moderate to severe atopic dermatitis will develop food allergies, but dermatologists can play a key role in preventing this comorbidity.
Up to 40% of children with moderate to severe atopic dermatitis will develop food allergies, but dermatologists can play a key role in preventing this comorbidity.
Up to 40% of children with...
06/10/2022
The Dermatologist
Cover Story
Tips for Physicians to Increase Adherence to Rosacea Therapy
05/13/2022
Julie C. Harper, MD, FAAD
If your patients are struggling with adhering to the treatment plan, there may be a good reason. When we find out why by actively listening, we can make adjustments and help them achieve and maintain a successful outcome.
If your patients are struggling with adhering to the treatment plan, there may be a good reason. When we find out why by actively listening, we can make adjustments and help them achieve and maintain a successful outcome.
If your patients are struggling...
05/13/2022
The Dermatologist
Cover Story
The Heterogeneity of Atopic Dermatitis
03/10/2022
Lindsay C. Strowd, MD
Improving patients’ quality of life is the goal of AD treatment. Further understanding the presenting clinical phenotypes, disease variation and comorbid conditions, and the impact of AD from the patient’s perspective will help us provide...
Improving patients’ quality of life is the goal of AD treatment. Further understanding the presenting clinical phenotypes, disease variation and comorbid conditions, and the impact of AD from the patient’s perspective will help us provide...
Improving patients’ quality of...
03/10/2022
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Current Issue

August 2024
Volume 32
Issue 5
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

Nancy Smail, RN
The Derm Nurse
“Where Would You Rather Be Than Right Here Right Now?”
04/16/2024
Nancy Smail, RN
Dermatology Nurses’ Association Annual Convention keynote speaker Dr Robert Kalb quotes Buffalo Bills coach Marv Levy in a walk-through of the new biologic landscape of psoriasis therapies.
Dermatology Nurses’ Association Annual Convention keynote speaker Dr Robert Kalb quotes Buffalo Bills coach Marv Levy in a walk-through of the new biologic landscape of psoriasis therapies.
Dermatology Nurses’ Association...
04/16/2024
The Dermatologist
The Relationship Between Psoriasis, Mental Health, and COVID-19
Videos
The Relationship Between Psoriasis, Mental Health, and COVID-19
09/08/2020
Dr Koo, member of the NPF medical board, outlines what the literature has said about mental health and COVID-19 and how this translates into the disease flares and severity in patients with psoriasis.
Dr Koo, member of the NPF medical board, outlines what the literature has said about mental health and COVID-19 and how this translates into the disease flares and severity in patients with psoriasis.
Dr Koo, member of the NPF...
09/08/2020
The Dermatologist
Psoriasis and COVID-19: Updates From International Registries
Partner Approved
Psoriasis and COVID-19: Updates From International Registries
06/11/2020
Lauren Mateja, Managing Editor
The Dermatologist spoke with investigators behind two prominent international registries dedicated to better understanding how concomitant psoriasis and COVID-19 can affect patient care and outcomes now and in the future.
The Dermatologist spoke with investigators behind two prominent international registries dedicated to better understanding how concomitant psoriasis and COVID-19 can affect patient care and outcomes now and in the future.
The Dermatologist spoke with...
06/11/2020
The Dermatologist
Dr Joy Wan
Conference Coverage
Case Reports: Insights Into Pediatric Eczema
05/09/2024
Jessica Garlewicz, Digital Managing Editor
During the second day of Spring Dermatology Week 2024, Ms Peggy Vernon and Dr Joy Wan outlined the objectives of their presentation,” Management of Pediatric Eczema / Case Discussion.”
During the second day of Spring Dermatology Week 2024, Ms Peggy Vernon and Dr Joy Wan outlined the objectives of their presentation,” Management of Pediatric Eczema / Case Discussion.”
During the second day of Spring...
05/09/2024
The Dermatologist
Survey Finds Patients Most Satisfied With IL-17 Inhibitors, 4-Week Dosing
Conference Coverage
Survey Finds Patients Most Satisfied With IL-17 Inhibitors, 4-Week Dosing
06/15/2020
A recent study found that patients had the highest overall treatment satisfaction with anti-IL-17 class therapies. The poster, presented at the American Academy of Dermatology Virtual Meeting Experience 2020, also...
A recent study found that patients had the highest overall treatment satisfaction with anti-IL-17 class therapies. The poster, presented at the American Academy of Dermatology Virtual Meeting Experience 2020, also...
A...
06/15/2020
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

The Dermatologist Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Latest Quizzes and Trivia

Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
Riya Gandhi, MA, Associate Editor
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Riya Gandhi, MA, Associate Editor
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist
Atopic Dermatitis + Eczema + Itch + Rash + Kids + Legs + Elbow + Knee
Quiz
Quiz: Navigating New Therapies in Atopic Dermatitis
04/10/2024
Riya Gandhi, MA, Associate Editor
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr...
04/10/2024
The Dermatologist
AD
Quiz
Trivia: Atopic Dermatitis Patients With Alopecia Areata
02/28/2024
Riya Gandhi, MA, Associate Editor
02/28/2024
The Dermatologist
AD
Quiz
Trivia: Itch Cycle and OTC Products
12/27/2023
12/27/2023
The Dermatologist
psoriasis
Quiz
Trivia: Recommended Treatment For Psoriasis
12/20/2023
Jessica Garlewicz, Digital Managing Editor
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate...
12/20/2023
The Dermatologist
Ilka Arun Netravali, MD, PhD, FAAD
Quiz
Dupilumab Mechanism of Action
11/07/2023
Jessica Garlewicz, Digital Managing Editor
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview...
11/07/2023
The Dermatologist

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement